A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease

There have been no longitudinal studies on α-synuclein as a potential biomarker for the progression of Parkinson's disease (PD). Here, blood plasma ‘total α-synuclein’ and ‘Ser-129 phosphorylated α-synuclein’ were assayed at 4–6 monthly intervals from a cohort of 189 newly-diagnosed patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Foulds, Penelope G., Diggle, Peter, Mitchell, J. Douglas, Parker, Angela, Hasegawa, Masato, Masuda-Suzukake, Masami, Mann, David M. A., Allsop, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756331/
https://www.ncbi.nlm.nih.gov/pubmed/23985836
http://dx.doi.org/10.1038/srep02540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756331/
https://www.ncbi.nlm.nih.gov/pubmed/23985836
http://dx.doi.org/10.1038/srep02540

Ejemplares similares